Fellman Vineta, Hellström-Westas Lena, Norman Mikael, Westgren Magnus, Källén Karin, Lagercrantz Hugo, Marsál Karel, Serenius Fredrik, Wennergren Margareta
Department of Obstetrics and Gynecology, Lund University Hospital, S-221 85 Lund, Sweden.
JAMA. 2009 Jun 3;301(21):2225-33. doi: 10.1001/jama.2009.771.
CONTEXT: Up-to-date information on infant survival after extremely preterm birth is needed for assessing perinatal care services, clinical guidelines, and parental counseling. OBJECTIVE: To determine the 1-year survival in all infants born before 27 gestational weeks in Sweden during 2004-2007. DESIGN, SETTING, AND PATIENTS: Population-based prospective observational study of extremely preterm infants (707 live-born and 304 stillbirths) born to 887 mothers in 904 deliveries (102 multiple births) in all obstetric and neonatal units in Sweden from April 1, 2004, to March 31, 2007. MAIN OUTCOME MEASURES: Infant survival to 365 days and survival without major neonatal morbidity (intraventricular hemorrhage grade >2, retinopathy of prematurity stage >2, periventricular leukomalacia, necrotizing enterocolitis, severe bronchopulmonary dysplasia). Associations between perinatal interventions and survival. RESULTS: The incidence of extreme prematurity was 3.3 per 1000 infants. Overall perinatal mortality was 45% (from 93% at 22 weeks to 24% at 26 weeks), with 30% stillbirths, including 6.5% intrapartum deaths. Of live-born infants, 91% were admitted to neonatal intensive care and 70% survived to 1 year of age (95% confidence interval [CI], 67%-73%). The Kaplan-Meier survival estimates for 22, 23, 24, 25, and 26 weeks were 9.8% (95% CI, 4%-23%), 53% (95% CI, 44%-63%), 67% (95% CI, 59%-75%), 82% (95% CI, 76%-87%), and 85% (95% CI, 81%-90%), respectively. Lower risk of infant death was associated with tocolytic treatment (adjusted for gestational age odds ratio [OR], 0.43; 95% CI, 0.36-0.52), antenatal corticosteroids (OR, 0.44; 95% CI, 0.24-0.81), surfactant treatment within 2 hours after birth (OR, 0.47; 95% CI, 0.32-0.71), and birth at a level III hospital (OR, 0.49; 95% CI, 0.32-0.75). Among 1-year survivors, 45% had no major neonatal morbidity. CONCLUSION: During 2004 to 2007, 1-year survival of infants born alive at 22 to 26 weeks of gestation in Sweden was 70% and ranged from 9.8% at 22 weeks to 85% at 26 weeks.
背景:评估围产期护理服务、临床指南和为家长提供咨询需要关于极早产儿存活情况的最新信息。 目的:确定2004 - 2007年瑞典所有孕27周前出生婴儿的1年生存率。 设计、地点和患者:基于人群的极早产儿前瞻性观察研究(707例活产儿和304例死产儿),这些婴儿由瑞典所有产科和新生儿科的887名母亲在904次分娩(102例多胎分娩)中产出,时间为2004年4月1日至2007年3月31日。 主要观察指标:婴儿存活至365天以及无重大新生儿疾病(脑室内出血>2级、早产儿视网膜病变>2期、脑室周围白质软化、坏死性小肠结肠炎、重度支气管肺发育不良)存活。围产期干预措施与存活之间的关联。 结果:极早产发生率为每1000例婴儿中有3.3例。总体围产期死亡率为45%(从孕22周时的93%降至孕26周时的24%),其中30%为死产,包括6.5%的产时死亡。在活产婴儿中,91%入住新生儿重症监护病房,70%存活至1岁(95%置信区间[CI],67% - 73%)。孕22、23、24、25和26周的Kaplan - Meier生存估计值分别为9.8%(95% CI,4% - 23%)、53%(95% CI,44% - 63%)、67%(95% CI,59% - 75%)、82%(95% CI,76% - 87%)和85%(95% CI,81% - 90%)。婴儿死亡风险较低与宫缩抑制剂治疗(校正孕周后的优势比[OR],0.43;95% CI,0.36 - 0.52)、产前使用糖皮质激素(OR,0.44;95% CI,0.24 - 0.81)、出生后2小时内使用表面活性剂治疗(OR,0.47;95% CI,0.32 - 0.71)以及在三级医院出生(OR,0.49;95% CI,0.32 - 0.75)有关。在1岁存活者中,45%无重大新生儿疾病。 结论:2004年至2007年期间,瑞典孕22至26周出生的活产婴儿1年生存率为70%,范围从孕22周时的9.8%至孕26周时的85%。
Obesity (Silver Spring). 2025-3
Arch Dis Child Fetal Neonatal Ed. 2025-6-19
JAMA Netw Open. 2024-11-4